Rep. Julie Johnson Buys Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares

Representative Julie Johnson (D-Texas) recently bought shares of Walgreens Boots Alliance, Inc. NASDAQ: WBA. In a filing disclosed on February 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Walgreens Boots Alliance stock on January 15th. The trade occurred in the Representative's "MERRILL LYNCH TAX EFFICIENT CORE" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Dell Technologies NYSE: DELL on 1/28/2025.
• Sold $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 1/28/2025.
• Sold $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 1/28/2025.
• Sold $1,001 - $15,000 in shares of ALLETE NYSE: ALE on 1/28/2025.
• Sold $1,001 - $15,000 in shares of PPG Industries NYSE: PPG on 1/27/2025.
• Purchased $1,001 - $15,000 in shares of Progressive NYSE: PGR on 1/24/2025.
• Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 1/24/2025.
• Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 1/24/2025.
• Sold $1,001 - $15,000 in shares of Morgan Stanley NYSE: MS on 1/24/2025.
• Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 1/17/2025.

Walgreens Boots Alliance Trading Down 0.5 %

NASDAQ:WBA traded down $0.05 during mid-day trading on Monday, hitting $9.70. The company had a trading volume of 12,483,077 shares, compared to its average volume of 31,095,116. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.47. The business's fifty day moving average is $10.31 and its two-hundred day moving average is $9.72. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a market cap of $8.38 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.26 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance's revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 earnings per share. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Institutional Trading of Walgreens Boots Alliance

Hedge funds have recently added to or reduced their stakes in the company. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Riverview Trust Co raised its holdings in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares in the last quarter. Colonial Trust Co SC raised its holdings in Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,297 shares in the last quarter. Finally, Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at $28,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of research analyst reports. TD Cowen dropped their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating on the stock in a research report on Tuesday, October 22nd. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Jefferies Financial Group decreased their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating for the company in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $13.19.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.